DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Aprotinin
Aprotinin
Cross-Linking of Alpha 2-Plasmin Inhibitor to Fibrin by Fibrin- Stabilizing Factor
United States Patent (19) 11 Patent Number: 6,019,993 Bal (45) Date of Patent: Feb
Safety and Efficacy of Prothrombin Complex Concentrate As First-Line
A Study on Ulinastatin in Preventing Post ERCP Pancreatitis
Antiproteases in Preventing Post-ERCP Acute Pancreatitis
Alternatives and Adjuncts to Blood Transfusion
Prothrombin Complex Concentrates: a Brief Review
Pharmacological Interventions for Acute Pancreatitis (Review)
Clinical Review: Prothrombin Complex Concentrates - Evaluation of Safety and Thrombogenicity
Stability of an Autologous Platelet Clot in the Pericardial Sac: an Experimental and Clinical Study
Prospectus Brochure of the Bond Bayer
Antifibrinolytic Therapy in Cardiac Surgery
Questions and Answers on the Review of Antifibrinolytic Medicines
Aprotinin Bovine, Recombinant, Expressed in Nicotiana (Tobacco)
Improved Tissue Glue Prepared by Using Cryoprecipitate
2019 Table of Drugs
A Compendium of Transfusion Practice Guidelines Edition 4.0 January 2021
Comparative Analysis of Prothrombin Complex Concentrate and Fresh
Top View
Tenncare Attestation List September 1, 2021
Comparative Effectiveness of In-Hospital Use of Recombinant
Syk Inhibits the Activity of Protein Kinase a By
Financial Statements Bayer Annual Report 2017 Bayer Group Consolidated Income Statements
Ortmann, MD, DESA, Martin W
Thrombin-Like Enzymes in Snake Venoms
List Item PDCO Monthly Report of Opinions on Paediatric Investigation
Effect of Ulinastatin on Post-Operative Blood Loss and Allogeneic
PRAC Agenda 06-09 April 2021
Bayer Aktiengesellschaft Bayer Capital Corporation B.V
WHO Drug Information Vol
BAYER AKTIENGESELLSCHAFT (Incorporated in the Federal Republic of Germany) As Issuer EUR 1,300,000,000 Subordinated Resettable Fixed Rate Notes Due 2075
Caring for Patients Who Refuse Blood
Discrimination Between Fibrin and Fibrinogen by a Monoclonal
Debt Issuance Programme Prospectus Dated March 24, 2017
Critical Quality Attributes Pertaining to Immunogenicity: a Preponderance of Evidence Approach to Control Strategies
Aprotinin Inhibits SARS-Cov-2 Replication
In-Silico Analysis of Potential Interaction of Drugs and the SARS-Cov-2 Spike Protein
Drugs Formulary
Injectables and Depots to Prolong Drug Action of Proteins and Peptides
Adult Inpatient/Emergency Department Procoagulant Clinical Practice Guideline (CPG) Cover Sheet
PRAC Draft Agenda of Meeting 28 September
Aprotinin a Popular Serine Proteases Inhibitors
TRASYLOL® (Aprotinin Injection) 01298181 12/03
Bayer Annual Report 2015 Consolidated Financial Statements Bayer Group Consolidated Income Statements
Therapeutic Application of Alpha-1-Antitrypsin in COVID-19
HEPATIC ARTERIAL LESIONS Reported Manifestations
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Antifibrinolytics for Pediatric CPB – Which Drug, How Much and When? Michael P